3 results
Approved WMORecruiting
The primary objective of the SPIRIT*HF study is to compare Spironolactone to Placebo in reducing the rate…
Approved WMOPending
Primary objective:- To determine the safety and optimal dose of three doses of a novel therapeutic vaccine (ISA104) consisting of 12 synthetic long peptides, as well as an adjuvant agent (AmplivantTM), in patients with chronic hepatitis B (cHBV),…
Approved WMOCompleted
To evaluate the efficacy of rVWF (vonicog alfa) prophylaxis based on the annualized bleeding rate (ABR) of spontaneous (not related to trauma) bleeding episodes in adult and pediatric / adolescent subjects (aged 12 to <18 years) during the…